TGFBI and glioma: This allows the measurement of BIGH3 levels in parent GMs, revealing TMZ’s anti-cancer impact; this makes the biosensor mentioned above show significant promise for its applicability to the identification of predictive biomarkers in GM-derived exosomes for glioma liquid biopsy (109).